Press Releases Keyword Search Year None20262025202420232022202120202019201820172016201520142013 March 27, 2026 Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference March 9, 2026 Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates February 23, 2026 Editas Medicine to Participate in Upcoming Investor Conferences
March 27, 2026 Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
March 9, 2026 Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
